BMS Archive

Plant · Scientific monograph

Ilex paraguariensis

Yerba mate

For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.

Research areas: Metabolic research, Dietary beverage research

Research overview

Historical use

Yerba mate leaves are traditionally prepared as an infusion. Beverage, soluble powder, capsule and standardized extract are distinct exposures [1].

Modern research context

A systematic review found human studies with varied designs and preparations, with many at moderate/high risk of bias and certainty ranging from moderate to very low [1]. A small 12-week capsule trial and a separate 34-person standardized-extract study produced different findings; the latter found no significant overall effect on measured cardiometabolic outcomes [2,3].

Adverse effects

Available trials are small/short and do not establish long-term safety. Beverage caffeine content and preparation vary; the cited studies do not establish a universal safety profile [1-3].

Contraindications

Do not generalize extract or capsule results to traditional beverage use or vice versa. Evidence does not establish disease prevention or treatment [1-3].

Clinical and phytochemical data

Used part

Leaves, used as infusion or processed extract; products and caffeine exposure vary [1-3].

Primary active compounds

  • Caffeine and caffeoylquinic acids are constituents discussed in the systematic review; content varies by product [1].

Mechanism of action

The clinical evidence does not establish a single mechanism or disease-modifying effect [1-3].

Pharmacokinetics

Absorption

PK varies with infusion/extract composition; no general human PK profile is established by these sources [1-3].

Distribution

Not characterized as a general plant-product profile.

Metabolism

Not characterized as a general plant-product profile.

Excretion

Not characterized as a general plant-product profile.

Safety and interactions

Drug interactions

No comprehensive species-specific clinical interaction profile established in the cited studies.

Toxicity

Long-term safety and risk across preparation methods are not resolved by small clinical trials [1-3].

Special precautions

Pregnancy

Medicinal-dose safety in pregnancy is not established by these sources.

Lactation

Medicinal-dose safety in lactation is not established by these sources.

Hepatic impairment

No impairment-specific clinical data identified.

Renal impairment

No impairment-specific clinical data identified.

Sources and references

  1. [1] Manuela F. B. José et al. Physiological effects of yerba maté (Ilex paraguariensis): a systematic review. Nutrition Reviews. 2023;81(9):1163–1179. PMID: 36647770. DOI: 10.1093/nutrit/nuac109.
  2. [2] Sun-Young Kim et al. Anti-obesity effects of Yerba Mate (Ilex Paraguariensis): a randomized, double-blind, placebo-controlled clinical trial. BMC Complementary and Alternative Medicine. 2015;15:338. PMID: 26408319. DOI: 10.1186/s12906-015-0859-1.
  3. [3] Karimi S. Gebara et al. A Randomized Crossover Intervention Study on the Effect a Standardized Maté Extract (Ilex paraguariensis A. St.-Hil.) in Men Predisposed to Cardiovascular Risk. Nutrients. 2021;13(1):14. PMID: 33374524. DOI: 10.3390/nu13010014.

Additional source links

Continue browsing